Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,469 | 252 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $689.73 | 34 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $504.23 | 30 | $0 (2024) |
| Gilead Sciences, Inc. | $466.21 | 33 | $0 (2024) |
| Celgene Corporation | $429.81 | 21 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $230.57 | 10 | $0 (2024) |
| ABBVIE INC. | $227.82 | 15 | $0 (2022) |
| Intercept Pharmaceuticals, Inc. | $178.45 | 8 | $0 (2024) |
| Janssen Biotech, Inc. | $169.21 | 9 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $146.06 | 13 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $136.43 | 9 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $939.96 | 40 | Takeda Pharmaceuticals U.S.A., Inc. ($292.98) |
| 2023 | $847.57 | 39 | Celgene Corporation ($176.93) |
| 2022 | $585.02 | 28 | Celgene Corporation ($252.88) |
| 2020 | $207.76 | 13 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($59.82) |
| 2019 | $716.35 | 46 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($148.69) |
| 2018 | $447.50 | 33 | Takeda Pharmaceuticals U.S.A., Inc. ($112.26) |
| 2017 | $724.48 | 53 | Takeda Pharmaceuticals America, Inc. ($146.06) |
All Payment Transactions
252 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $32.86 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/19/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $20.10 | General |
| Category: GI | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $34.22 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: LIVER DISEASE | ||||||
| 10/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.17 | General |
| 10/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/30/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.59 | General |
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Immunology | ||||||
| 08/19/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Immunology | ||||||
| 08/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Oncology | ||||||
| 07/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $33.28 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 674 | 821 | $142,295 | $71,114 |
| 2022 | 10 | 623 | 749 | $117,815 | $52,054 |
| 2021 | 10 | 649 | 779 | $116,385 | $50,990 |
| 2020 | 13 | 684 | 798 | $114,745 | $45,198 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 77 | 77 | $30,800 | $21,763 | 70.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 138 | 138 | $31,050 | $18,743 | 60.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 176 | 302 | $49,830 | $18,686 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 59 | $13,275 | $5,824 | 43.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 77 | 77 | $3,850 | $2,503 | 65.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 35 | 40 | $4,000 | $1,338 | 33.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 100 | 106 | $7,950 | $1,066 | 13.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 11 | 11 | $990.00 | $833.91 | 84.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $550.00 | $357.50 | 65.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 141 | 141 | $31,725 | $19,757 | 62.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 154 | 245 | $40,425 | $14,959 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 78 | $17,550 | $7,066 | 40.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 69 | 76 | $7,600 | $3,033 | 39.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 24 | 24 | $1,840 | $1,645 | 89.4% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 12 | 12 | $3,500 | $1,590 | 45.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 17 | 22 | $5,050 | $1,566 | 31.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 94 | 103 | $7,725 | $899.13 | 11.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 24 | 24 | $1,200 | $772.77 | 64.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 24 | $1,200 | $767.28 | 63.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 128 | 128 | $28,800 | $18,291 | 63.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 164 | 262 | $43,230 | $16,002 | 37.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 74 | $16,650 | $6,722 | 40.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 83 | 94 | $9,400 | $3,527 | 37.5% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 27 | 27 | $2,430 | $1,794 | 73.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 14 | 14 | $2,100 | $1,757 | 83.7% |
About Dr. Sybil Sandoval, MD
Dr. Sybil Sandoval, MD is a Internal Medicine healthcare provider based in Avon, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1407833106.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sybil Sandoval, MD has received a total of $4,469 in payments from pharmaceutical and medical device companies, with $939.96 received in 2024. These payments were reported across 252 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,469).
As a Medicare-enrolled provider, Sandoval has provided services to 2,630 Medicare beneficiaries, totaling 3,147 services with total Medicare billing of $219,357. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Avon, CT
- Active Since 12/23/2005
- Last Updated 03/07/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1407833106
Products in Payments
- ENTYVIO (Biological) $486.46
- ZEPOSIA (Drug) $429.81
- XIFAXAN (Drug) $336.57
- DUPIXENT (Biological) $282.56
- Entyvio (Biological) $240.51
- OCALIVA (Drug) $178.45
- UCERIS (Drug) $102.25
- VOQUEZNA (Drug) $98.60
- Creon (Drug) $97.67
- IBSRELA (Drug) $97.44
- XIFAXANIBSD (Drug) $93.69
- ZEPATIER (Drug) $89.38
- Amitiza (Drug) $87.85
- STELARA (Biological) $78.37
- TRULANCE (Drug) $78.30
- Trulance (Drug) $74.24
- Cologuard Collection Kit (Device) $71.34
- MYRBETRIQ (Drug) $71.13
- OMVOH (Drug) $68.28
- Linzess (Drug) $66.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Avon
Dr. Monica Grafals, M.d, M.D
Internal Medicine — Payments: $498,418
Ingrid Grafals, Md, MD
Internal Medicine — Payments: $13,888
Dr. Sheila Rice, M.d, M.D
Internal Medicine — Payments: $13,874
Dr. Xiusheng Qin, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $11,247
Namrata Shah, Md, MD
Internal Medicine — Payments: $10,414
Dr. Andrew Filiatraut, Do, DO
Internal Medicine — Payments: $10,250